Ascendis Pharma A/S Announces Year-End 2018 Financial Results and Business Update Conference Call on April 3

Ads

You May Also Like

T2 Biosystems Announces New Data at IDWeek 2016

LEXINGTON, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company ...

Insmed Submits New Drug Application to FDA for ALIS in NTM Lung Disease Caused by MAC

ALIS previously designated as an orphan drug, breakthrough therapy and Qualified Infectious Disease Product ...

Delcath Issues Letter to Stockholders

NEW YORK, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH) (“Delcath” ...